Giuliano La Fratta
Finanzdirektor/CFO bei AETERNA ZENTARIS INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Giuliano La Fratta
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AETERNA ZENTARIS INC. | Finanzdirektor/CFO | 24.01.2022 | - |
Karriereverlauf von Giuliano La Fratta
Ehemalige bekannte Positionen von Giuliano La Fratta
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Corporate Officer/Principal | - | - |
Ausbildung von Giuliano La Fratta
Concordia University | Undergraduate Degree |
Statistik
International
Kanada | 4 |
Operativ
Director of Finance/CFO | 1 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 2 |
Commercial Services | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AETERNA ZENTARIS INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Commercial Services |
- Börse
- Insiders
- Giuliano La Fratta
- Erfahrung